Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Antigen processing and presentation 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Antigen processing and presentation
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬1. Antigen processing and presentation
|
||||||||||||||||||||||||||||||||||||
2 | Antigen processing and presentation 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬Antigen processing and presentation
| Zanolimumab | 046 [1] 46 💬2. Antigen processing and presentation
|
||||||||||||||||||||||||||||||||||||
3 | Cell adhesion molecules 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Cell adhesion molecules
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬3. Cell adhesion molecules
|
||||||||||||||||||||||||||||||||||||
4 | Cell adhesion molecules 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬Cell adhesion molecules
| Zanolimumab | 046 [1] 46 💬4. Cell adhesion molecules
|
||||||||||||||||||||||||||||||||||||
5 | Cytokine-cytokine receptor interaction 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Cytokine-cytokine receptor interaction
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬5. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||
6 | Cytokine-cytokine receptor interaction 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬Cytokine-cytokine receptor interaction
| Zanolimumab | 046 [1] 46 💬6. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||
7 | Hematopoietic cell lineage 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Hematopoietic cell lineage
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬7. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||
8 | Hematopoietic cell lineage 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬Hematopoietic cell lineage
| Zanolimumab | 046 [1] 46 💬8. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||
9 | Human immunodeficiency virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Human immunodeficiency virus 1 infection
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬9. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||
10 | Human immunodeficiency virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬Human immunodeficiency virus 1 infection
| Zanolimumab | 046 [1] 46 💬10. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||
11 | Human T-cell leukemia virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Human T-cell leukemia virus 1 infection
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬11. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||
12 | Human T-cell leukemia virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬Human T-cell leukemia virus 1 infection
| Zanolimumab | 046 [1] 46 💬12. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||
13 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬13. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||
14 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Zanolimumab | 046 [1] 46 💬14. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||
15 | Primary immunodeficiency 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Primary immunodeficiency
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬15. Primary immunodeficiency
|
||||||||||||||||||||||||||||||||||||
16 | Primary immunodeficiency 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬Primary immunodeficiency
| Zanolimumab | 046 [1] 46 💬16. Primary immunodeficiency
|
||||||||||||||||||||||||||||||||||||
17 | T cell receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬T cell receptor signaling pathway
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬17. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||
18 | T cell receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬T cell receptor signaling pathway
| Zanolimumab | 046 [1] 46 💬18. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||
19 | Th1 and Th2 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Th1 and Th2 cell differentiation
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬19. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||
20 | Th1 and Th2 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬Th1 and Th2 cell differentiation
| Zanolimumab | 046 [1] 46 💬20. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||
21 | Th17 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Th17 cell differentiation
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬21. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||
22 | Th17 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬Th17 cell differentiation
| Zanolimumab | 046 [1] 46 💬22. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||
23 | Viral life cycle - HIV-1 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Viral life cycle - HIV-1
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬23. Viral life cycle - HIV-1
|
||||||||||||||||||||||||||||||||||||
24 | Viral life cycle - HIV-1 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬Viral life cycle - HIV-1
| Zanolimumab | 046 [1] 46 💬24. Viral life cycle - HIV-1
|
||||||||||||||||||||||||||||||||||||
25 | Virion - Human immunodeficiency virus 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Virion - Human immunodeficiency virus
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬25. Virion - Human immunodeficiency virus
|
||||||||||||||||||||||||||||||||||||
26 | Virion - Human immunodeficiency virus 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬Virion - Human immunodeficiency virus
| Zanolimumab | 046 [1] 46 💬26. Virion - Human immunodeficiency virus
|
||||||||||||||||||||||||||||||||||||
27 | Yersinia infection 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Yersinia infection
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬27. Yersinia infection
|
||||||||||||||||||||||||||||||||||||
28 | Yersinia infection 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬Yersinia infection
| Zanolimumab | 046 [1] 46 💬28. Yersinia infection
|
Antigen processing and presentation
1 gene, 2 drugs (DrugBank) and 14 diseases
Cell adhesion molecules
1 gene, 2 drugs (DrugBank) and 14 diseases
Cytokine-cytokine receptor interaction
1 gene, 2 drugs (DrugBank) and 14 diseases
Hematopoietic cell lineage
1 gene, 2 drugs (DrugBank) and 14 diseases
Human immunodeficiency virus 1 infection
1 gene, 2 drugs (DrugBank) and 14 diseases
Human T-cell leukemia virus 1 infection
1 gene, 2 drugs (DrugBank) and 14 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
1 gene, 2 drugs (DrugBank) and 14 diseases
Primary immunodeficiency
1 gene, 2 drugs (DrugBank) and 14 diseases
T cell receptor signaling pathway
1 gene, 2 drugs (DrugBank) and 14 diseases
Th1 and Th2 cell differentiation
1 gene, 2 drugs (DrugBank) and 14 diseases
Th17 cell differentiation
1 gene, 2 drugs (DrugBank) and 14 diseases
Viral life cycle - HIV-1
1 gene, 2 drugs (DrugBank) and 14 diseases
Virion - Human immunodeficiency virus
1 gene, 2 drugs (DrugBank) and 14 diseases
Yersinia infection
1 gene, 2 drugs (DrugBank) and 14 diseases